Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neurosurgery: Pediatrics

• Publication date

  2015-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.3171/2014.12.PEDS14522PMID 25837886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.

  2014cited by this paper
• Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

  2014cited by this paper
• Outcome of overt stroke in sickle cell anaemia, a single institution's experience

  2014cited by this paper
• Sickle cell anemia: intracranial stenosis and silent cerebral infarcts in children with low risk of stroke.

  2014cited by this paper
• National trends in incidence rates of hospitalization for stroke in children with sickle cell disease

  2013cited by this paper
• Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

  2012cited by this paper
• The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.

  2012cited by this paper
• Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.

  2011cited by this paper
• Significance of Focal Cerebral Hyperperfusion as a Cause of Transient Neurologic Deterioration After Extracranial-Intracranial Bypass for Moyamoya Disease: Comparative Study With Non-Moyamoya Patients Using N-Isopropyl-p-[123I]Iodoamphetamine Single-Photon Emission Computed Tomography

  2011cited by this paper
• Clinical and Angiographic Outcomes From Indirect Revascularization Surgery for Moyamoya Disease in Adults and Children: A Review of 63 Procedures

  2011cited by this paper
• Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

  2011cited by this paper
• Multiple burr hole surgery as a treatment modality for pediatric moyamoya disease

  2010cited by this paper
• Chronic transfusion practice for children with sickle cell anaemia and stroke

  2009cited by this paper
• Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease?

  2009cited by this paper
• Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.

  2009cited by this paper
• Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.

  2008cited by this paper
• Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.

  2006cited by this paper
• Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.

  2005cited by this paper
• Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography.

  2004cited by this paper
• Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.

  2003cited by this paper
• How does angiogenesis develop in pediatric moyamoya disease after surgery?

  2003cited by this paper
• Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.

  2002cited by this paper
• Stroke prevention trial in sickle cell anemia.

  1998cited by this paper
• Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

  1998cited by this paper
• Cerebrovascular accidents in sickle cell disease: rates and risk factors.

  1998cited by this paper
• An indirect revascularization method in the surgical treatment of moyamoya disease--various kinds of indirect procedures and a multiple combined indirect procedure.

  1998cited by this paper
• Sickle cell disease: imaging of cerebrovascular complications.

  1998cited by this paper
• Dural inversion procedure for moyamoya disease. Technical note.

  1997cited by this paper
• Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease.

  1996cited by this paper
• Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.

  1995cited by this paper
• Pial synangiosis for moyamoya syndrome in children.

  1995cited by this paper
• Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease.

  1984cited by this paper
• A new surgical treatment of moyamoya disease in children: a preliminary report.

  1981cited by this paper
• Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

  1969cited by this paper

• Outcomes of Bypass Surgery in Patients with Moyamoya Syndrome Secondary To Sickle Cell Disease: a Multicenter Study

  2026cites this paper
• Primary and secondary stroke prophylaxis in children with sickle cell anemia: a meta-analysis

  2025cites this paper
• How I do it – extracranial-intracranial bypass surgery integrating STA-MCA anastomosis, synangiosis, MMA supply, and preservation of recipient artery perforators: the Integrated Method

  2025cites this paper
• Outcomes of surgical revascularization for pediatric moyamoya disease and syndrome

  2024cites this paper
• Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future

  2024cites this paper
• Neurovascular Manifestations of Sickle Cell Disease

  2024cites this paper
• Indications for cerebral revascularization for moyamoya syndrome in pediatric sickle cell disease determined by Delphi methodology.

  2024cites this paper
• Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study

  2023cites this paper
• Abnormal Neurologic Findings in Patients With Sickle Cell Disease Without a History of Major Neurologic Events.

  2023cites this paper
• Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives

  2023cites this paper
• Surgical revascularizations for pediatric moyamoya: a systematic review, meta-analysis, and meta-regression analysis

  2023cites this paper
• Hematopoietic Stem Cell Transplantation Stabilizes Cerebral Vasculopathy in High-Risk Pediatric Sickle Cell Disease Patients: Evidence From a Referral Transplant Center

  2022influential citation
• Cerebrovascular disease in sickle cell disease

  2022cites this paper
• Socioeconomic factors associated with pediatric moyamoya disease hospitalizations: a nationwide cross-sectional study.

  2022cites this paper
• Revascularization Is Associated With a Reduced Stroke Risk in Patients With Sickle Cell–Associated Moyamoya Syndrome

  2022cites this paper
• Intracranial Vascular Abnormalities in Children.

  2021cites this paper
• Indications for transfusion in the management of sickle cell disease.

  2021cites this paper
• Updates in the management of moyamoya disease

  2021cites this paper
• Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres.

  2020cites this paper
• Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion.

  2020cites this paper
• Cerebral Revascularization for Moyamoya syndrome associated with Sickle Cell Disease: A systematic review of literature on the role of EC-IC bypass in treating neurological manifestations of pediatric patients with Sickle Cell Disease.

  2020cites this paper
• Clinical Presentation and Stroke Incidence Differ by Moyamoya Etiology

  2020cites this paper
• Childhood Stroke

  2020cites this paper
• Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease

  2019cites this paper
• Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.

  2019cites this paper
• Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis.

  2019cites this paper
• Encephaloduroarteriosynangiosis

  2019cites this paper
• Neurologic Complications of Sickle Cell Disease

  2019cites this paper
• Feasibility and safety of intraoperative BOLD functional MRI cerebrovascular reactivity to evaluate extracranial-to-intracranial bypass efficacy.

  2019cites this paper
• Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease

  2019cites this paper
• Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.

  2019cites this paper
• Anemia in the Young and Old

  2019cites this paper
• Anemia at the Extremes of Life: Congenital Hemolytic Anemia

  2018cites this paper
• Neurological Manifestations of Sickle Cell Disease and Their Impact on Allogeneic Hematopoietic Stem Cell Transplantation

  2018cites this paper
• Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.

  2018cites this paper
• Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.

  2017cites this paper
• Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome

  2017cites this paper
• Sickle Cell Disease.

  2017cites this paper
• Pediatric Neurovascular Disease

  2017cites this paper
• Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia

  2017cites this paper
• Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience

  2017cites this paper
• Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy

  2016cites this paper
• Stroke recurrence in adult sickle cell patients: it is time for action!

  2016cites this paper
• Management of Sickle Cell Disease in Children

  2016cites this paper
• Sickle Cell Disease and Stroke: Diagnosis and Management

  2016cites this paper
• Central nervous system complications and management in sickle cell disease.

  2016cites this paper
• Structural causes of ischemic and hemorrhagic stroke in children: moyamoya and arteriovenous malformations

  2015cites this paper